好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cross-modality Transformation from SWI to QSM Based on U-net Gan
Aging, Dementia, and Behavioral Neurology
P3 - Poster Session 3 (5:00 PM-6:00 PM)
12-012

To achieve efficient and accurate quantitative susceptibility mapping (QSM) reconstruction based on susceptibility-weighted imaging (SWI) for brain magnetic susceptibility biomarker measurements in clinical diagnosis and longitudinal monitoring of neurodegenerative disease.

QSM enables non-invasive quantification of tissue magnetic susceptibility, providing direct measurements related to iron content, calcium deposition, and other paramagnetic or diamagnetic substances in the brain. Due to the high time and computational cost of QSM reconstruction, in daily neurological practice and in the majority of prior cohort studies, imaging protocols have primarily included susceptibility-weighted imaging (SWI) alone, thereby missing the ability to provide quantitative evaluations of magnetic susceptibility.

 

5083 healthy subjects with brain MRIs (SWIs and QSMs) were randomly selected from UKBiobank dataset. Data preprocessing (including normalization, orientation alignment, and registration) was performed to enhance sample consistency. A Generative Adversarial Network (GAN) with a U-Net generator and a multi-layer convolutional neural network has been designed as the generative model architecture. The FID score and the slice-wise correlation coefficient are used to evaluate the results.

 

Compared with QSM from UKbiobank data, the U-Net GAN-reconstructed QSM achieved an FID score of 1.6031 ± 0.17 and a slice-wise correlation coefficient (p < 0.01).

This study presents an efficient and high-quality QSM reconstruction method that can be directly generated from SWI data, providing more convenient quantitative indicators of iron deposition and calcification in practical use, further assisting neurologists in identifying crucial imaging biomarkers such as microbleed lesions and brain gray matter volume, offering intelligent support for neurological disease diagnosis and treatment decision-making.
Authors/Disclosures
Xingqi Pan
PRESENTER
Miss Pan has nothing to disclose.
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Chiheng Zhou Ms. Zhou has nothing to disclose.
Jinming Zhang, PhD Dr. Zhang has received personal compensation for serving as an employee of IPSEN BIOPHARMACEUTICALS, INC..
Denise (. YI, PhD Dr. YI has received personal compensation for serving as an employee of Servier Pharmaceuticals.
Zhengxing Huang, PhD Mr. Huang has nothing to disclose.
Yi-Cheng Zhu, MD, PhD (Peking Union Medical College Hospital) Dr. Zhu has nothing to disclose.